Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
HEMO from Roeselare, company number BE0438817904, closed financial year 2025 with a result of € 60,015 after tax. For that financial year HEMO recorded a gross margin of € 150,330 and equity of € 661,461. Compared with financial year 2024, the result moved from € 25,462 to € 60,015. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 661,461
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 60,015
▲ 136% vs 2024
Profit after tax over the fiscal year.
€ 101,460
▲ 156% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 359,031.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 16,791
▲ € 16,642 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,167
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 87,187 | € 104,288 | € 105,276 | € 150,330 | ▲ 43% |
| Profit after taxes | € 17,021 | € 26,097 | € 25,462 | € 60,015 | ▲ 136% |
| Equity | € 549,886 | € 575,984 | € 601,446 | € 661,461 | ▲ 10% |
| Total debts | € 401,998 | € 402,942 | € 412,457 | € 431,768 | ▲ 5% |
| Cash | € 271,215 | € 77,904 | € 39,587 | € 101,460 | ▲ 156% |
| Land & buildings | € 668,246 | € 634,320 | € 600,395 | € 596,015 | ▼ 1% |
| Retained profit | € 247,456 | € 273,553 | € 299,015 | € 359,031 | ▲ 20% |
| Balance sheet total | € 951,885 | € 978,926 | € 1,013,903 | € 1,093,229 | ▲ 8% |
Key figures of HEMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HEMO?
What happened at HEMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 60,015 (▲ 136% vs 2024). filed late Source: NBB ↗
- Briseïs Dewulf became a director. NBB
- Jürgen Dewulf became a director. NBB
- Hendrik Dewulf stepped down as director. NBB
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 17,021 profit in 2022 to € 60,015 profit in 2025.
Paid € 45,684 in corporate taxes since 2022.
Best year ever: 2025, with € 60,015 profit.
A new publication or filing at HEMO? We notify you, reason included.
Follow HEMODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind HEMO are Briseïs Dewulf and Jürgen Dewulf.
Directors
According to the 2025 annual accounts
Briseïs Dewulf
Director
since 2025
Jürgen Dewulf
Managing director
since 2025
Hendrik Dewulf
Managing director
· until 2025
Establishments
Establishment units
Physical locations of this company
Noordlaan 80
8800 Roeselare
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0438.817.904
- VAT number
- BE 0438.817.904
- Registered office
- Noordlaan 80, 8800 Roeselare
- Names & denominations
- HEMO
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 November 1989
- Peppol
- Active · Active since 2 Jan 2026
- Activities · NACE
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Verhuur van niet-residentiële gebouwen